N@N

Amit Hazan Maintained (ABT) at Hold with Increased Target to $64 on, Jan 30th, 2018

Amit Hazan of Citigroup, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $59 to $64 on, Jan 30th, 2018.

Amit has made no other calls on ABT in the last 4 months.

There are 9 other peers that have a rating on ABT. Out of the 9 peers that are also analyzing ABT, 1 agrees with Amit's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Sean Lavin of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 22nd, 2018

These are the ratings of the 8 analyists that currently disagree with Amit

---

• David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
• Joanne Wuensch of "BMO Capital" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
• Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
• Margaret Kaczor of "William Blair" Upgraded from Hold to Buy on, Thursday, January 25th, 2018
• Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $70 on, Thursday, January 25th, 2018
• Michael Weinstein of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Thursday, January 25th, 2018
• Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $71 on, Thursday, January 25th, 2018
• Vijay Kumar of "Evercore ISI Group" Initiated at Buy and Held Target at $64 on, Wednesday, January 3rd, 2018

Contributing Sources

---